OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Mechanisms of cisplatin resistance and targeting of cancer stem cells: Adding glycosylation to the equation
José Alexandre Ferreira, Andreia Peixoto, Manuel Neves, et al.
Drug Resistance Updates (2015) Vol. 24, pp. 34-54
Open Access | Times Cited: 143
José Alexandre Ferreira, Andreia Peixoto, Manuel Neves, et al.
Drug Resistance Updates (2015) Vol. 24, pp. 34-54
Open Access | Times Cited: 143
Showing 1-25 of 143 citing articles:
The Roles of Autophagy in Cancer
Chul Won Yun, Sang Hun Lee
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 11, pp. 3466-3466
Open Access | Times Cited: 842
Chul Won Yun, Sang Hun Lee
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 11, pp. 3466-3466
Open Access | Times Cited: 842
The CD47‐SIRPα signaling axis as an innate immune checkpoint in cancer
Hanke L. Matlung, Katka Szilagyi, Neil Barclay, et al.
Immunological Reviews (2017) Vol. 276, Iss. 1, pp. 145-164
Closed Access | Times Cited: 451
Hanke L. Matlung, Katka Szilagyi, Neil Barclay, et al.
Immunological Reviews (2017) Vol. 276, Iss. 1, pp. 145-164
Closed Access | Times Cited: 451
Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5
Xing Qin, Haiyan Guo, Xiaoning Wang, et al.
Genome biology (2019) Vol. 20, Iss. 1
Open Access | Times Cited: 360
Xing Qin, Haiyan Guo, Xiaoning Wang, et al.
Genome biology (2019) Vol. 20, Iss. 1
Open Access | Times Cited: 360
Identification of MRP2 as a targetable factor limiting oxaliplatin accumulation and response in gastrointestinal cancer
Khine Nyein Myint, Riya Biswas, Yan Li, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 260
Khine Nyein Myint, Riya Biswas, Yan Li, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 260
In Vitro Anticancer Activity and in Vivo Biodistribution of Rhenium(I) Tricarbonyl Aqua Complexes
Kevin M. Knopf, Brendan L. Murphy, Samantha N. MacMillan, et al.
Journal of the American Chemical Society (2017) Vol. 139, Iss. 40, pp. 14302-14314
Open Access | Times Cited: 173
Kevin M. Knopf, Brendan L. Murphy, Samantha N. MacMillan, et al.
Journal of the American Chemical Society (2017) Vol. 139, Iss. 40, pp. 14302-14314
Open Access | Times Cited: 173
The signaling pathways and targets of traditional Chinese medicine and natural medicine in triple-negative breast cancer
Zimei Yang, Qiuhua Zhang, Linghong Yu, et al.
Journal of Ethnopharmacology (2020) Vol. 264, pp. 113249-113249
Closed Access | Times Cited: 168
Zimei Yang, Qiuhua Zhang, Linghong Yu, et al.
Journal of Ethnopharmacology (2020) Vol. 264, pp. 113249-113249
Closed Access | Times Cited: 168
Precision medicine in head and neck cancer
Orit Kaidar‐Person, Ziv Gil, Salem Billan
Drug Resistance Updates (2018) Vol. 40, pp. 13-16
Closed Access | Times Cited: 162
Orit Kaidar‐Person, Ziv Gil, Salem Billan
Drug Resistance Updates (2018) Vol. 40, pp. 13-16
Closed Access | Times Cited: 162
Tunicamycin specifically aggravates ER stress and overcomes chemoresistance in multidrug-resistant gastric cancer cells by inhibiting N-glycosylation
Jian Wu, Sheng Chen, Hao Liu, et al.
Journal of Experimental & Clinical Cancer Research (2018) Vol. 37, Iss. 1
Open Access | Times Cited: 162
Jian Wu, Sheng Chen, Hao Liu, et al.
Journal of Experimental & Clinical Cancer Research (2018) Vol. 37, Iss. 1
Open Access | Times Cited: 162
DHA exhibits synergistic therapeutic efficacy with cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via modulation of iron metabolism
Jing Du, Xu Wang, Yanchun Li, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 7
Open Access | Times Cited: 132
Jing Du, Xu Wang, Yanchun Li, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 7
Open Access | Times Cited: 132
Cancer Stem Cells—Key Players in Tumor Relapse
Monica Marzagalli, Fabrizio Fontana, M. Raimondi, et al.
Cancers (2021) Vol. 13, Iss. 3, pp. 376-376
Open Access | Times Cited: 115
Monica Marzagalli, Fabrizio Fontana, M. Raimondi, et al.
Cancers (2021) Vol. 13, Iss. 3, pp. 376-376
Open Access | Times Cited: 115
Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms
Fei Li, Zaosong Zheng, Wei Chen, et al.
Drug Resistance Updates (2023) Vol. 68, pp. 100938-100938
Closed Access | Times Cited: 92
Fei Li, Zaosong Zheng, Wei Chen, et al.
Drug Resistance Updates (2023) Vol. 68, pp. 100938-100938
Closed Access | Times Cited: 92
Epigenetic modification of m6A regulator proteins in cancer
Yumin Wang, Yan Wang, Harsh Patel, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 80
Yumin Wang, Yan Wang, Harsh Patel, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 80
Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases
Yumin Wang, Jing Hu, Shuang Wu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 72
Yumin Wang, Jing Hu, Shuang Wu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 72
Selenium and tellurium in the development of novel small molecules and nanoparticles as cancer multidrug resistance reversal agents
Enrique Domínguez‐Álvarez, Bálint Rácz, Małgorzata Anna Marć, et al.
Drug Resistance Updates (2022) Vol. 63, pp. 100844-100844
Open Access | Times Cited: 70
Enrique Domínguez‐Álvarez, Bálint Rácz, Małgorzata Anna Marć, et al.
Drug Resistance Updates (2022) Vol. 63, pp. 100844-100844
Open Access | Times Cited: 70
Single-cell transcriptome analysis reveals the association between histone lactylation and cisplatin resistance in bladder cancer
Fei Li, Henghui Zhang, Yu‐An Huang, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101059-101059
Closed Access | Times Cited: 50
Fei Li, Henghui Zhang, Yu‐An Huang, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101059-101059
Closed Access | Times Cited: 50
Recent Advances of Platinum‐Based Anticancer Complexes in Combinational Multimodal Therapy
Tianyuan Zhong, Jie Yu, Yong Pan, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 22
Open Access | Times Cited: 42
Tianyuan Zhong, Jie Yu, Yong Pan, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 22
Open Access | Times Cited: 42
Cancer plasticity in therapy resistance: Mechanisms and novel strategies
Xing Niu, Wenjing Liu, Zhang Yinling, et al.
Drug Resistance Updates (2024) Vol. 76, pp. 101114-101114
Closed Access | Times Cited: 15
Xing Niu, Wenjing Liu, Zhang Yinling, et al.
Drug Resistance Updates (2024) Vol. 76, pp. 101114-101114
Closed Access | Times Cited: 15
Old drugs, novel ways out: Drug resistance toward cytotoxic chemotherapeutics
Ruud H. Wijdeven, Baoxu Pang, Yehuda G. Assaraf, et al.
Drug Resistance Updates (2016) Vol. 28, pp. 65-81
Closed Access | Times Cited: 166
Ruud H. Wijdeven, Baoxu Pang, Yehuda G. Assaraf, et al.
Drug Resistance Updates (2016) Vol. 28, pp. 65-81
Closed Access | Times Cited: 166
Pro-survival autophagy and cancer cell resistance to therapy
Chandan Kanta Das, Mahitosh Mandal, Donat Kögel
Cancer and Metastasis Reviews (2018) Vol. 37, Iss. 4, pp. 749-766
Open Access | Times Cited: 145
Chandan Kanta Das, Mahitosh Mandal, Donat Kögel
Cancer and Metastasis Reviews (2018) Vol. 37, Iss. 4, pp. 749-766
Open Access | Times Cited: 145
Towards the overcoming of anticancer drug resistance mediated by p53 mutations
Xin Cao, Jiayun Hou, Quanlin An, et al.
Drug Resistance Updates (2019) Vol. 49, pp. 100671-100671
Closed Access | Times Cited: 139
Xin Cao, Jiayun Hou, Quanlin An, et al.
Drug Resistance Updates (2019) Vol. 49, pp. 100671-100671
Closed Access | Times Cited: 139
Emerging platinum(iv ) prodrugs to combat cisplatin resistance: from isolated cancer cells to tumor microenvironment
Zhigang Wang, Zhiqin Deng, Guangyu Zhu
Dalton Transactions (2019) Vol. 48, Iss. 8, pp. 2536-2544
Closed Access | Times Cited: 128
Zhigang Wang, Zhiqin Deng, Guangyu Zhu
Dalton Transactions (2019) Vol. 48, Iss. 8, pp. 2536-2544
Closed Access | Times Cited: 128
Long non-coding RNAs as a determinant of cancer drug resistance: Towards the overcoming of chemoresistance via modulation of lncRNAs
Wenxiao Jiang, Jun Xia, Shangdan Xie, et al.
Drug Resistance Updates (2020) Vol. 50, pp. 100683-100683
Closed Access | Times Cited: 115
Wenxiao Jiang, Jun Xia, Shangdan Xie, et al.
Drug Resistance Updates (2020) Vol. 50, pp. 100683-100683
Closed Access | Times Cited: 115
Application of capsaicin as a potential new therapeutic drug in human cancers
Shengping Zhang, Dian Wang, Jingying Huang, et al.
Journal of Clinical Pharmacy and Therapeutics (2019) Vol. 45, Iss. 1, pp. 16-28
Open Access | Times Cited: 106
Shengping Zhang, Dian Wang, Jingying Huang, et al.
Journal of Clinical Pharmacy and Therapeutics (2019) Vol. 45, Iss. 1, pp. 16-28
Open Access | Times Cited: 106
The bad seed: Cancer stem cells in tumor development and resistance
Elle Koren, Yaron Fuchs
Drug Resistance Updates (2016) Vol. 28, pp. 1-12
Closed Access | Times Cited: 103
Elle Koren, Yaron Fuchs
Drug Resistance Updates (2016) Vol. 28, pp. 1-12
Closed Access | Times Cited: 103
Long non-coding RNAs: An emerging powerhouse in the battle between life and death of tumor cells
Xing-dong Xiong, Xingcong Ren, Meng-yun Cai, et al.
Drug Resistance Updates (2016) Vol. 26, pp. 28-42
Closed Access | Times Cited: 94
Xing-dong Xiong, Xingcong Ren, Meng-yun Cai, et al.
Drug Resistance Updates (2016) Vol. 26, pp. 28-42
Closed Access | Times Cited: 94
